Ephedrine supplements lack "significant" abuse, should not be controlled -- coalition.
This article was originally published in The Tan Sheet
Executive Summary
EPHEDRINE-CONTAINING SUPPLEMENT ABUSE REJECTED BY INDUSTRY COALITION as a reason to assign controlled substance status to the OTC drug and dietary supplement ingredient. In April 17 comments to FDA on the World Health Organization's potential rescheduling of ephedrine, the Dietary Supplement Safety and Science Coalition (DSSSC) stresses the history of use and safety of the ingredient, stating "ephedrine is not a controlled substance in the U.S. today, nor should it be internationally."
You may also be interested in...
Metabolife Begins $1.5 Mil. Preemptive Campaign Against "20/20" Angle
Metabolife International has launched a $1.5 mil. radio, print and Internet campaign to preemptively combat what the company expects to be a negative report by ABC-TV's "20/20" on the firm's ephedra-containing supplement Metabolife 356.
Metabolife Begins $1.5 Mil. Preemptive Campaign Against "20/20" Angle
Metabolife International has launched a $1.5 mil. radio, print and Internet campaign to preemptively combat what the company expects to be a negative report by ABC-TV's "20/20" on the firm's ephedra-containing supplement Metabolife 356.
Metabolife Begins $1.5 Mil. Preemptive Campaign Against "20/20" Angle
Metabolife International has launched a $1.5 mil. radio, print and Internet campaign to preemptively combat what the company expects to be a negative report by ABC-TV's "20/20" on the firm's ephedra-containing supplement Metabolife 356.